Read the story on the WPVI-TV Action News 11 Philadelphia, PA website. Includes an interview with Dr. Allan Magaziner in Cherry Hill, New Jersey, a TACT2 investigator.
News
For daring to study a discredited therapy, this doctor earned scorn — and a $37 million grant
Visit STAT to read the background of TACT and TACT2, and how Dr. Lamas has risked his reputation to bring the rigors of clinical research to what some considered quackery.
Ensayo clínico busca beneficios en pacientes diabéticos
9/29/2016 – The National Center for Complementary and Integrative Health (NCCIH) que forma parte de los Institutos Nacionales de Salud (NIH, por sus siglas en inglés) ha otorgado $37M a Mount Sinai Medical Center de la Florida y al Duke Clinical Research Institute para dar comienzo al segundo Ensayo Clínico que Evalúa la Terapia de Quelación (TACT2).
Feds Fund Groundbreaking $37 Million Chelation Heart Study
Chelation therapy, an alternative-medicine technique dismissed as fringe medicine by many conventional heart doctors, is getting a shot in the arm from federal officials who are providing a $37 million grant to study its benefits as a mainstream cardiovascular treatment.
Chelation Remains A Hopeful Heart Therapy
Read the Huffington Post blog post about TACT and TACT2 by Joel Kahn, M.D.
In the News
- TACTful Perseverance and a Black Swan Event
Tactful Perseverance and a Black Swan Event –TACT2 to follow-up on post-MI diabetic patients. “I have to admit that until 1999, I had no particular interest in studying a pariah therapy called EDTA chelation — really just not my style.” // “When the Duke staff distributed the previously blinded analyses, all of us turned to the bottom line, ...more
- How Treating the Elephant in the Room Became a Black Swan Event: Toxic Metals and Cardiovascular Disease
Gervasio A. Lamas, MD of Mount Sinai Medical Center and Columbia University Medical Center presented at Brigham and Women’s Hospital Cardiovascular Grand Rounds in March 2019. His presentation was titled, “How ...more - Chelation for CLI in Diabetic Patients Shows Potential in Small Series
Before and after photos presented at 2019 International Symposium on Endovascular Therapy (ISET) show the effect of chelation therapy in diabetic patients with critical limb ischemia (CLI), highlighting its potential ...more - Chelation therapy surprises experts with positive results in diabetic patients with CLI
An e-poster and presentation at the 31st International Symposium on Endovascular Therapy (ISET) highlighted positive results from a pilot study of edetate disodium-based chelation in diabetic patients with critical limb ischaemia ...more - Alternative Heart Medicine Becoming Mainstream
Scott Doughty, MD aims to decrease the number heart attacks, strokes, and deaths for individuals through TACT2 and chelation therapy. Dr. Doughty is the startup inspiration behind U.P. Holistic Medicine, ...more - Reducing Cardiac Risks for Diabetics through Chelation TherapyChelation therapy was developed in the 1930s and was designed to remove heavy metals from the blood of severely metal-poisoned patients. In 2012, findings from the Trial to Assess Chelation ...more
- TACT Research Presented at the American Heart Association’s Scientific Sessions 2018
The Trial to Assess Chelation Therapy (TACT) demonstrated a major improvement in ischemic cardiac events in diabetic patients randomized to edetate disodium-based chelation. Research findings presented at the American Heart ...more - Crime of the Century: The Failure to Prevent the Lead Poisoning Pandemic (Video)Clinician-scientist Bruce Lanphear, MD, has produced a video on the lead pandemic: “Over the last century the planet has experienced the largest mass contamination in history, a pandemic of lead ...more
- Lead could be fueling America’s high blood pressure epidemicThere’s one possible reason so many Americans, especially those living in inner cities, have high blood pressure: lead exposure. Researchers tested people’s bones for evidence they took in lead over the ...more
- Free download: TACT2 overview with Dr. Gervasio Lamas
Learn about the Trial to Assess Chelation Therapy 2 (TACT2) in this free presentation from the study chairman, Dr. Gervasio Lamas. Audio included.more - New study could help decide whether chelation benefits the heartChelation therapy has long been scorned by many in the medical community. But after a major study suggested it was somewhat effective for heart disease, the alternative health treatment is ...more
- US deaths from lead exposure 10 times higher than thought, study suggestsLead exposure may be responsible for nearly 10 times more deaths in the United States than previously thought, according to a new study from The Lancet Public Health. Watch the video ...more
- What is chelation, and how does it work?Dr. Jeff Baker, of Clinical Research Prime in Idaho Falls, Idaho, explains how removing toxic metals from the body with chelation therapy could help patients with cardiovascular issues. His clinic ...more
- Free info session on diabetes, heart disease, and TACT2TACT2 investigator Dr. Richard Nahas will present a free information session on diabetes, heart disease, and the TACT2 study on Tuesday, February 13, 7:00–8:30 p.m., at Ben Franklin Place in ...more
- Nueva investigación sobre diabetes mira hacia el pasado
Los diabéticos Tipo 2 con historial de paro cardíaco pueden encontrar una solución a sus complicaciones. ¿La clave? Una droga desarrollada en la década de 1950.more - To treat diabetes in new ways, TACT2 investigators look to the pastType 2 diabetics with a history of cardiac arrest might find a solution to their complications. The key? A drug developed in the 1950s.more
- Chelation therapy: As good as statins, aspirin for your heart?Tact2 investigator Dr. Gervasio Lamas explains how chelation therapy could be a “game changer” in the treatment and prevention of heart disease.more
- Little Rock Arkansas: The Arkansas Heart Hospital is participating in TACT2March 28, 2017 Little Rock, Arkansas: The Arkansas Heart Hospital is now involved in a clinical trial that could lead to a new way to treat heart disease. Jancey Sheets has ...more
Alternative Heart Treatment Moving Into the Mainstream
Chelation therapy, an alternative technique long dismissed by conventional heart doctors, has taken a giant step toward becoming a first-line mainstream medical treatment, thanks to a boost from the National Institutes of Health.
CardioBrief: Second Trial of Chelation Therapy Wins Early Support
The National Institutes of Health (NIH) is giving money to support the planning of a second trial to test the potential role of chelation therapy in treating patients with myocardial infarction.